During the past decade, University of Louisville Health Sciences Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Louisville Health Sciences Center" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Children's Hospital Medical Center, Cincinnati" with 1 trials sponsored, "Duke University" with 1 trials sponsored, "GlycoMimetics Incorporated" with 1 trials sponsored and "National Eye Institute (NEI)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Louisville Health Sciences Center" #1 collaborator was "Christopher Reeve Paralysis Foundation" with 2 trials as a collaborator, "AO Clinical Investigation and Publishing Documentation" with 1 trials as a collaborator, "Brooke Army Medical Center" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "Louisiana State University Health Sciences Center in New Orleans" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Louisville Health Sciences Center" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Migraine" (2 trials), "Spinal Cord Injury" (2 trials), "Anemia, Sickle Cell" (1 trials) and "Headache" (1 trials). Many other conditions were trialed in "University of Louisville Health Sciences Center" in a lesser frequency.

Most popular intervention types in "University of Louisville Health Sciences Center" are "Drug" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Amitriptyline" (1 trials), "No Treatment Given" (1 trials) and "Riluzole" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Louisville Health Sciences Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "University of Louisville Health Sciences Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Louisville Health Sciences Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Louisville Health Sciences Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".